Posaconazol Accord 40 mg/ml, Suspension zum Einnehmen

7680673660010 CH-67366 suspension

Associated product:

POSACONAZOL Accord susp 40 mg/ml buvable 105 ml
Posaconazol Accord 40 mg/ml, Suspension zum Einnehmen
Posaconazol Accord 40 mg/ml, Suspension zum Einnehmen
Posaconazol Accord 40 mg/ml, Suspension zum Einnehmen
1 / 3
google

Article details

Package size
105
Selling units
105
Measure
ml
Galenic form
suspension
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
20/09/2025
Summary of Product Characteristics
Français
20/09/2025
Summary of Product Characteristics
Italien
20/09/2025
Patient information leaflet
Allemand
17/09/2025
Patient information leaflet
Français
17/09/2025
Patient information leaflet
Italien
17/09/2025

Detailed composition

Substance Quantity Type Category
(N/A)
200.0 MG Substance Wirkstoff (Principe actif)
(N/A)
25.0 MG Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.75 G Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance AROMA
(N/A)
10.86 MG Substance HBESI
(N/A)
- Substance FNIDK
(N/A)
11.4 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
2.52 MG Substance HBESI

Reimbursement information

Public price
CHF 574.50
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/12/2020

Authorization holder

Accord Healthcare AG

4103 Bottmingen

Authorization information

Swissmedic authorization number
67366
Drug name
Posaconazol Accord, Suspension zum Einnehmen
Galenic form
SUOR
ATC Code
J02AC04
Authorization status
Z
Dispensing category
B
First authorization
30/01/2020
Authorization expiration date
31/12/9999
IT Number
08.06.0.
Domain
Human medicine
Field of application
Antimykotikum

Package details

Description (FR)
POSACONAZOL Accord susp 40 mg/ml buvable 105 ml
Description (DE)
POSACONAZOL Accord Susp 40 mg/ml zum Einneh 105 ml
Market launch
30/01/2020
Narcotic (BTM)
No

Original drug

Noxafil, Konzentrat zur Herstellung einer Infusionslösung
GTIN: 7680651720019
CHF 456.15
View original